Latest Market Positioning News

Mount Burgess Mining announces the immediate resignation of long-serving Chairman Nigel Forrester due to ill health, appointing Dr. Steve Lennon as the new Executive Chairman to steer the company forward.

Australian Bond Exchange Holdings has completed a $683,180 private placement, issuing over 17 million shares to strengthen its financial position and support expansion and cost-cutting initiatives.

Comms Group Limited has inked a binding agreement to acquire TasmaNet, a leading Tasmanian communications provider, significantly expanding its network assets and customer base. This strategic move is expected to lift Comms Group’s proforma revenue to around $75 million and EBITDA to $9-10 million annually.

Webjet’s board has unanimously dismissed BGH’s unsolicited acquisition offer, citing undervaluation and significant uncertainties. The company remains open to proposals that better serve shareholder interests.

Ava Risk Group has landed a $1.1 million contract to deploy its advanced fibre sensing technology at a major ADNOC oil and gas field in Abu Dhabi, reinforcing its strategic partnership with Honeywell and its foothold in critical infrastructure security.

Aspen Group has launched a $74 million equity raising to reduce debt and capitalize on growth opportunities in affordable housing, maintaining its FY25 earnings guidance.

Mesoblast has been granted a seven-year orphan-drug exclusivity by the FDA for its cell therapy Ryoncil, reinforcing its market position in treating steroid-refractory acute graft versus host disease in children.

Genetic Technologies Limited has announced significant leadership changes, appointing Michael Walker as Executive Chairman and Managing Director, alongside new executive and board members.

Proteomics International Laboratories has secured a key Chinese patent for its OxiDx oxidative stress test, broadening its intellectual property coverage across major global markets until 2039. This milestone reinforces the company’s position in precision diagnostics for sports and veterinary health.

Xero Limited reported a robust FY25 with 23% revenue growth to NZ$2.1 billion and a 30% rise in net profit, driven by strategic investments in AI and product innovation. Leadership changes and a CEO pay review underscore the company’s global ambitions.

Euro Manganese Inc. reported a net loss of CAD 9.174 million for the half-year ending March 31, 2025, while making significant progress on its Chvaletice Manganese Project, including securing key permits and strategic status under EU and Czech frameworks. The company’s development hinges on completing a crucial private placement and share purchase plan to sustain operations.

Euro Manganese advances its Chvaletice manganese project with key regulatory approvals, leadership appointments, and a $9.8 million capital raise, while reporting a narrowed Q3 net loss.